Filing Flows › Starling Oncology (STLN) › Patient services revenue
Starling Oncology (STLN) Patient services revenue by quarter
Starling Oncology's Patient services revenue was $60.0M in Q3 2026 (third quarter 2026), +2% from Q2 2026. Over the last 6 quarters it ranged from $53.1M (Q1 2025) to $60.2M (Q3 2025).
| Quarter | Patient services revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $60.0M | +2% | -0.3% |
| Q2 2026 | $58.8M | -0.4% | +5% |
| Q1 2026 | $59.1M | -2% | +11% |
| Q3 2025 | $60.2M | +8% | — |
| Q2 2025 | $55.9M | +5% | — |
| Q1 2025 | $53.1M | — | — |
Q3 2026 at a glance
Starling Oncology, Q3 2026: revenue $170M (+24% year over year), operating margin -1.8%, net loss $15.7M, operating cash flow $10.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Starling Oncology's Patient services revenue?
Starling Oncology's Patient services revenue was $60.0M in Q3 2026 (third quarter 2026), +2% from Q2 2026.
How has Starling Oncology's Patient services revenue changed?
Over the last 6 quarters it ranged from $53.1M (Q1 2025) to $60.2M (Q3 2025).